Heart failure: an update from the last years and a look at the near future

M Riccardi, AM Sammartino, M Piepoli… - ESC heart …, 2022 - Wiley Online Library
In the last years, major progress occurred in heart failure (HF) management. Quadruple
therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst …

[HTML][HTML] D-dimer: old dogmas, new (COVID-19) tricks

G Lippi, F Mullier, EJ Favaloro - Clinical Chemistry and Laboratory …, 2023 - degruyter.com
D-dimer is a fibrin degradation product encompassing multiple cross-linked D domains
and/or E domains present in the original fibrinogen molecule, whose generation is only …

Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme

EL Petersen, A Goßling, G Adam… - European Heart …, 2022 - academic.oup.com
Aims Long-term sequelae may occur after SARS-CoV-2 infection. We comprehensively
assessed organ-specific functions in individuals after mild to moderate SARS-CoV-2 …

[HTML][HTML] A multisystem, cardio-renal investigation of post-COVID-19 illness

AJ Morrow, R Sykes, A McIntosh, A Kamdar, C Bagot… - Nature medicine, 2022 - nature.com
The pathophysiology and trajectory of post-Coronavirus Disease 2019 (COVID-19)
syndrome is uncertain. To clarify multisystem involvement, we undertook a prospective …

[HTML][HTML] Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European …

FJ Charchar, PR Prestes, C Mills, SM Ching… - Journal of …, 2024 - journals.lww.com
Hypertension, defined as persistently elevated systolic blood pressure (SBP)> 140 mmHg
and/or diastolic blood pressure (DBP) at least 90 mmHg (International Society of …

[HTML][HTML] Acute and post-acute COVID-19 cardiovascular complications: a comprehensive review

C Kole, Ε Stefanou, N Karvelas, D Schizas… - … drugs and therapy, 2023 - Springer
Abstract Purpose of Review The risk of cardiovascular complications due to SARS-CoV-2
are significantly increased within the first 6 months of the infection. Patients with COVID-19 …

The impact of COVID-19 and COVID vaccination on cardiovascular outcomes

Z Akhtar, M Trent, A Moa, TC Tan… - European Heart …, 2023 - academic.oup.com
COVID-19 is an independent risk factor for cardiovascular disease. COVID-19 vaccination
may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or …

[HTML][HTML] Inflammatory and cardiac biomarkers in relation with post-acute COVID-19 and mortality: what we know after successive pandemic waves

C Lionte, V Sorodoc, RE Haliga, C Bologa… - Diagnostics, 2022 - mdpi.com
Background: Biomarkers were correlated with mortality in critically ill COVID-19 patients. No
prediction tools exist for noncritically ill COVID-19 patients. We aimed to compare the …

[HTML][HTML] Cardiovascular complications of viral respiratory infections and COVID-19

P Franczuk, M Tkaczyszyn, M Kulak, E Domenico… - Biomedicines, 2022 - mdpi.com
Viral respiratory infections (VRI) are the most prevalent type of infectious diseases and
constitute one of the most common causes of contact with medical care. Regarding the …

[HTML][HTML] Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health

EL Presti, D Nuzzo, W Al Mahmeed, K Al-Rasadi… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Abstract Obesity, type 2 diabetes (T2DM), hypertension (HTN), and Cardiovascular Disease
(CVD) often cluster together as “Cardiometabolic Disease”(CMD). Just under 50% of …